The pharmaceutical industry has gone through heaps and bounds of multiple shake ups due to the Covid-19 pandemic. And as we move forward, it has become more important than ever to strike a balance between pharmaceutical innovation and accessibility to medication.
Raman Singh, Chief Executive Officer, Juniper Biologics shares with us on how his company are looking ways to support Singapore’s efforts to be the next frontier in pharmaceutical services.

Breakfast Bites: 4 at-home tests that reveal how well you’re aging
05:23

Bigger Pic: How smart money is positioning between the Iran oil shock and the AI boom
10:26

Companies To Watch: Is Lululemon losing its shine as growth slows?
10:17